For Investors

Press Releases

ReWalk Robotics Announces Closing of $4.37 Million Public Offering

02/25/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 25, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the closing and funding of its previously announced public offering of 19,000,000 ordinary shares at a price to the public of $0.23 per

Read More
Read More

ReWalk Robotics Announces Pricing of $4.37 Million Public Offering of Ordinary Shares

02/21/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 21, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the pricing of a public offering of 19,000,000 ordinary shares, offered at a price to the public of $0.23 per share, for gross proceeds

Read More
Read More

ReWalk Robotics Announces Proposed Public Offering of Ordinary Shares

02/20/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 20, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced that it intends to offer and sell, subject to market and other conditions, its ordinary shares in a public offering. The offering is

Read More
Read More

ReWalk Announces 510k FDA Submission for ReStore™ Exo-Suit for Stroke Rehabilitation

02/19/19

Innovation in robotic rehabilitation technology will provide the first-of-its-kind medical device to rehab clinics nationwide, to treat the millions of patients with lower limb disability due to stroke MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Feb.

Read More
Read More

ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices

02/13/19

Cigna Transitions to Case-by-Case Review Process, Eliminating Non-Coverage Policy MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 13, 2019 /PRNewswire/ --  ReWalk Robotics, Ltd.  (Nasdaq: RWLK) ("ReWalk" or the "Company"), disclosed today that Cigna Corporation , a leading global health service

Read More
Read More

ReWalk Robotics Reports Fourth Quarter 2018 Financial Results

02/08/19

— 2018 total revenue of $6.5 million and $1.6 million during the fourth quarter of 2018 — — Preparing for 2019 commercial launch of ReStore for stroke patients — YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 08, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.

Read More
Read More

ReWalk Robotics to Report Fourth Quarter and Year-End 2018 Financial Results on February 8, 2019

02/05/19

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Feb. 05, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and year-end 2018 financial results on Friday, February 8, 2019 , before the U.S.

Read More
Read More

ReWalk Announces Preliminary Fiscal Year 2018 Revenue

01/14/19

ReStore clinical study accrual and follow up completed YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Jan. 14, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced preliminary, unaudited revenue for the fiscal year ended December 31, 2018 .

Read More
Read More

ReWalk Robotics Announces Closing of $12.1 Million Public Offering

11/20/18

Underwriters Exercise In Full Option to Purchase Additional Securities YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Nov. 20, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the closing of its previously announced underwritten public

Read More
Read More

ReWalk Robotics Announces Pricing of $11.6 Million Public Offering

11/16/18

YOKNEAM ILIT, ISRAEL and MARLBOROUGH, Mass. , Nov. 16, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the pricing of an underwritten public offering of 38,660,722 units at a price to the public of $0.30 per unit.

Read More
Read More

United Spinal Association Issues Recommendation for Insurers to Consider Powered Exoskeleton Devices Medically Necessary for Paralyzed Individuals

11/15/18

Recommendation points to health benefits, safety of exoskeletons for all qualified spinal cord injured users MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Nov. 15, 2018 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company") applauds United Spinal Association's

Read More
Read More

ReWalk Announces Placement of 500th Exoskeleton System

11/09/18

Robotic exoskeleton manufacturer has provided life changing medical devices for persons with spinal cord injury in 26 countries MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Nov. 9, 2018 /PRNewswire/ --  ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company") announced today that the

Read More
Read More
Displaying 157 - 168 of 299